VOYA Investment Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Buy
29,421
+3,579
+14% +$32.1K ﹤0.01% 2084
2026
Q1
$210K Sell
25,842
-1,371
-5% -$12.4K ﹤0.01% 2100
2025
Q4
$183K Hold
27,213
﹤0.01% 2168
2025
Q3
$236K Sell
27,213
-14,282
-34% -$111K ﹤0.01% 2112
2025
Q2
$261K Sell
41,495
-24
-0.1% -$159 ﹤0.01% 2213
2025
Q1
$266K Sell
41,519
-4,107
-9% -$34K ﹤0.01% 2179
2024
Q4
$367K Sell
45,626
-383
-0.8% -$3.69K ﹤0.01% 2090
2024
Q3
$581K Sell
46,009
-46,835
-50% -$605K ﹤0.01% 1917
2024
Q2
$1.18M Buy
92,844
+57,635
+164% +$580K ﹤0.01% 1546
2024
Q1
$168K Sell
35,209
-2,421
-6% -$11.2K ﹤0.01% 2507
2023
Q4
$181K Buy
37,630
+2,875
+8% +$17.6K ﹤0.01% 2605
2023
Q3
$252K Buy
34,755
+560
+2% +$4.47K ﹤0.01% 2407
2023
Q2
$254K Sell
34,195
-362
-1% -$2.85K ﹤0.01% 2466
2023
Q1
$239K Sell
34,557
-33,675
-49% -$310K ﹤0.01% 2435
2022
Q4
$701K Sell
68,232
-954
-1% -$16.8K ﹤0.01% 1834
2022
Q3
$1.26M Buy
69,186
+36,245
+110% +$1.57M ﹤0.01% 1514
2022
Q2
$1.69M Sell
32,941
-3,656
-10% -$189K ﹤0.01% 1174
2022
Q1
$2.69M Sell
36,597
-753
-2% -$67.1K 0.01% 1024
2021
Q4
$5.34M Buy
37,350
+14,012
+60% +$2.41M 0.01% 820
2021
Q3
$4.84M Sell
23,338
-511
-2% -$113K 0.01% 847
2021
Q2
$5.06M Sell
23,849
-3,084
-11% -$565K 0.01% 856
2021
Q1
$4.88M Buy
26,933
+357
+1% +$71.1K 0.01% 845
2020
Q4
$2.96M Buy
26,576
+5,650
+27% +$601K 0.01% 982
2020
Q3
$2.27M Buy
20,926
+722
+4% +$88K 0.01% 986
2020
Q2
$1.68M Buy
20,204
+3,816
+23% +$146K ﹤0.01% 1082
2020
Q1
$223K Buy
16,388
+2,095
+15% +$17.7K ﹤0.01% 2075
2019
Q4
$57K Buy
14,293
+3,932
+38% +$17.1K ﹤0.01% 2629
2019
Q3
$52K Hold
10,361
﹤0.01% 2501
2019
Q2
$61K Buy
10,361
+2,496
+32% +$19.6K ﹤0.01% 2546
2019
Q1
$87K Sell
7,865
-340
-4% -$10.7K ﹤0.01% 2450
2018
Q4
$302K Buy
8,205
+605
+8% +$23.4K ﹤0.01% 2020
2018
Q3
$286K Hold
7,600
﹤0.01% 2170
2018
Q2
$204K Buy
7,600
+736
+11% +$24.9K ﹤0.01% 2352
2018
Q1
$288K Hold
6,864
﹤0.01% 2128
2017
Q4
$170K Sell
6,864
-50
-0.7% -$1.22K ﹤0.01% 2394
2017
Q3
$158K Hold
6,914
﹤0.01% 2456
2017
Q2
$159K Buy
6,914
+1,082
+19% +$21.2K ﹤0.01% 2470
2017
Q1
$149K Hold
5,832
﹤0.01% 2369
2016
Q4
$147K Hold
5,832
﹤0.01% 2389
2016
Q3
$243K Sell
5,832
-101,101
-95% -$13.1M ﹤0.01% 2167
2016
Q2
$15.5M Buy
106,933
+7,547
+8% +$865K 0.04% 435
2016
Q1
$10.3M Buy
99,386
+24,882
+33% +$2.67M 0.03% 534
2015
Q4
$12.5M Buy
74,504
+1,042
+1% +$160K 0.03% 482
2015
Q3
$10.4M Buy
73,462
+66,436
+946% +$14.9M 0.03% 545
2015
Q2
$1.56M Sell
7,026
-142
-2% -$25K ﹤0.01% 1179
2015
Q1
$1.19M Hold
7,168
﹤0.01% 1348
2014
Q4
$850K Hold
7,168
﹤0.01% 1552
2014
Q3
$598K Hold
7,168
﹤0.01% 1786
2014
Q2
$662K Hold
7,168
﹤0.01% 1784
2014
Q1
$649K Hold
7,168
﹤0.01% 1776
2013
Q4
$734K Hold
7,168
﹤0.01% 1674
2013
Q3
$453K Hold
7,168
﹤0.01% 1979
2013
Q2
$294K Buy
+7,168
New +$311K ﹤0.01% 2260

Other funds holding NVAX

VOYA Investment Management's NVAX Position: Q2 2026 in Review

VOYA Investment Management increased its Novavax (NVAX) stake by 14% in Q2 2026, buying an estimated $32.1K and bringing the position to 29,421 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

VOYA Investment Management first reported a position in NVAX in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.5M in Q2 2016. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • VOYA Investment Management held 29,421 shares of Novavax worth $277K as of Q2 2026.
  • VOYA Investment Management bought 3,579 Novavax shares in Q2 2026, an estimated $32.1K.
  • Novavax made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2084 holding.
  • VOYA Investment Management first reported a position in Novavax in Q2 2013 and has held it in 53 quarters since.
  • VOYA Investment Management's Novavax position peaked at $15.5M in Q2 2016.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.